Artificial Intelligence

Companion Diagnostics Market to Enjoy Advancements in AI, Big Data, NGS and Surpass the Value of 15 billion by 2028

Published

2 years ago

July 21, 2022

Westford, USA, July 21, 2022 (GLOBE NEWSWIRE) — The term “companion diagnostic” (CDx) is used to describe in vitro diagnostic devices (IVDs) that are essential for the safe and effective use of certain therapeutic products. A CDx may be used to select patients for therapy, monitor therapy, or predict a patient’s response to therapy. As such, a companion diagnostics market can play a critical role in personalized medicine.

The first FDA-approved CDx was the HercepTest, which is used to guide treatment with the HER2-targeted cancer therapies Herceptin (trastuzumab) and Tykerb (lapatinib). The HercepTest is a laboratory test that detects the presence of HER2 protein on the surface of tumor cells. Patients whose tumors test positive for HER2 are more likely to benefit from treatment with a HER2-targeted therapy.

Since its approval in 1998, several other CDx tests have been developed and approved by FDA. For example, the Vectra DA Test is used to help guide treatment with immune checkpoint inhibitors, such as Opdivo (nivolumab), Yervoy (ipilimumab), and Keytruda (pembrolses of death worldwide, it is no surprise that there is a great deal of research being devoted to finding new ways to detect and treat the disease in the global companion diagnostics market. One area that has seen significant advancements in recent years is companion diagnostics – tests that can be used to identify which patients are most likely to respond positively to a particular treatment.

Get sample copy of this report:

https://skyquestt.com/sample-request/companion-diagnostics-market

17 million New Cancer Cases and 10 million Deaths Each Year, World is Crumpling

With cancer being one of the leading causes of death worldwide, it is no surprise that there is a great deal of research being devoted to finding new ways to detect and treat the disease. One area that has seen significant advancements in recent years is companion diagnostics market – tests that can be used to identify which patients are most likely to respond positively to a particular treatment.

While the use of companion diagnostics is still in its early stages, it is already having a positive impact on patient outcomes. In one study, the use of a companion diagnostic test helped researchers identify which patients with advanced non-small cell lung cancer were most likely to benefit from the drug crizotinib (Xalkori). As a result of this study, crizotinib was approved for use in patients with this specific type of lung cancer.

In another study, companion diagnostics were used to determine which patients with metastatic melanoma were most likely to respond positively to the immunotherapy drug pembrolizumab (Keytruda). This study led to the drug being approved for use in this particular group of patients.

While the use of companion diagnostics market is still in its early stages, it is already having a positive impact on patient outcomes. In one study, the use of a companion diagnostic test helped researchers identify which patients with advanced non-small cell lung cancer were most likely to benefit from the drug crizotinib (Xalkori). As a result of this study, crizotinib was approved for use in patients with this specific type of lung cancer.

Recent Trends in Companion Diagnostics Market

Here are some of the most recent developments that have covered in the recent report published by SkyQuest on companion diagnostics market:

New tools for early detection of cancer. Companion diagnostics tests can help to identify signs and symptoms of cancer early, when it is easier to treat. This is especially important for cancer patients who may have fewer symptoms early on and may therefore be less likely to receive proper treatment if they are diagnosed at an early stage.
Interpretation of genetic data. Companion diagnostics tests can help to interpret genetic data that is collected from patients. This information can help clinicians to better understand the characteristics of a patient’s disease and to develop specific treatment plans.
Improved understanding of autism spectrum disorder. Tests in companion diagnostics market can help to identify markers associated with autism spectrum disorder (ASD). This information can help clinicians to better understand ASD and to develop more effective treatments for this condition.
More accurate diagnosis of diabetes mellitus type 2. Companion diagnostics tests can help to identify signs of diabetes mellitus type 2 (DM2) and to better diagnose this condition.
Improved understanding of hypertension. Companion diagnostics tests can help to identify the presence of signs of high blood pressure (HTN) and to confirm the diagnosis. The ability to track HTN over time can improve the management of this disease in both early and late stages, which will ultimately improve patient outcomes.
Support for personalized medicine. Companion diagnostics tests can help physicians to personalize treatment plans for patients with cancer or malignancies, treating only those who need more intense therapy.
Supporting personal health decisions. Companion diagnostics tests can assist in making better lifestyle choices that could reduce one’s risk for certain diseases, such as heart disease and diabetes.

Increased Attention to Personalized Medication to Flourish Companion Diagnostics Market

Companion diagnostics are tests that help to guide treatment decisions for patients with cancer heart disease and diabetes, among others. They can be used to identify which patients are more likely to respond to a certain type of treatment, and they can also be used to monitor how well a patient is responding to treatment. Companion diagnostics are growing in popularity because they offer a more personalized approach to cancer care.

The use of companion diagnostics in personalized medicine has increased significantly in recent years. In many cases, these tests can help to identify which patients are likely to respond to a particular treatment and which are not. This information is critical in helping to tailor treatment plans to individual patients and improve outcomes.

There are a number of reasons why the use of companion diagnostics market has increased in recent years. First, there has been an increasing focus on personalized medicine and the need to tailor treatment plans to individual patients. Second, advances in technology have made it possible to perform these tests more accurately and with greater precision. Finally, as our understanding of cancer biology has improved, we have been able to develop more targeted therapies that are more likely to be effective in specific subgroups of patients.

The future of personalized medicine will likely see even greater use of companion diagnostics market. As the knowledge continues to expand, the market will be able identify ever-more precise subgroups of patients who are most likely to benefit from a particular therapy. Additionally, as new treatments continue to be developed, companion diagnostic market will play an increasingly important role.

Browse summary of the report and Complete Table of Contents (ToC):

https://skyquestt.com/report/companion-diagnostics-market

CROs are Topping the Charts in Companion Diagnostics Market

There is no denying that contract research organizations (CROs) are playing an increasingly important role in the development of companion diagnostics. As the demand for personalized medicine continues to grow, CROs are uniquely positioned to help pharmaceutical and biotechnology companies create tailored treatments based on a patient’s individual genetic makeup.

CDx are diagnostic tests that are used to select patients who are most likely to benefit from a particular treatment. They can also be used to monitor a patient’s response to therapy and make adjustments as needed. Companion diagnostics market can be used for a variety of different conditions, including cancer, cardiovascular disease, and infectious diseases.

The development of CDx is a complex process that requires expertise in both molecular biology and clinical medicine. CROs that offer CDx services typically have teams of highly trained scientists and physicians who work together to develop these tests. In many cases, CROs are able to develop tests faster than pharmaceutical companies or academic institutions because they have access to the latest technology and equipment. In addition, CROs often have established relationships with key opinion leaders in the field of personalized medicine, which gives them a unique advantage in terms of developing new tests.

One example of a CRO in the global companion diagnostics market is Incyte Corporation. Incyte is one of the largest CROs in the world and has developed more than 100 companion diagnostics products. Incyte’s expertise in companion diagnostics has helped it to become one of the foremost providers of innovative diagnostic solutions for the global pharma and biotech markets.

Other CROs are working on technologies that can help doctors diagnose diseases more accurately and more quickly. For example, AbbVie is developing a test that can identify certain types of cancer at an earlier stage than traditional tests. And Geisinger is working on a test that can detect Alzheimer’s disease early on in the patient’s journey to diagnosis.

These innovations in the companion diagnostics market are making it possible for patients to get better care sooner and saving taxpayers money in the long run. Thanks to CROs, the market is continuing to lead the way in developing new ways to improve accuracy and affordability in companion diagnostics as well attract more market revenue.

With so much at stake, CROs are constantly exploring ways to improve their products and services. Their goal is to provide quality diagnostic solutions that help physicians make better decisions about patient care.

Application of NGS, AI and BIG Data in Companion Diagnostics Market is On the Rise

As the world becomes increasingly digital, so too is the way we diagnose and treat disease. Advances in genomics, proteomics, informatics, and artificial intelligence are helping to transform how we diagnose and treat diseases. In this blog section, we will explore some of the key applications of NGS, AI, and big data in companion diagnostics.

Currently, companion diagnostics market is using a variety of technologies such as next-generation sequencing (NGS), big data, and artificial intelligence (AI) to analyze and interpret data. In the near future, these technologies will be augmented by big data to provide even more insights into the patient’s health. Here are some examples of from the Companion Diagnostics market report about how this is being used:

Machine learning algorithms are being used to analyze large amounts of data from patient DNA samples in order to more accurately identify genetic variants that may be associated with certain diseases. This information can then be used to tailor treatment plans specifically for each individual patient.
NGS technology is also being used in the companion diagnostics market to develop new methods for early detection of cancer. By looking for specific changes in the DNA of healthy cells, doctors can sometimes catch cancerous cells before they even start to cause symptoms.
The use of BIG data is helping researchers gain a better understanding of how different diseases progress and which treatments are most effective at different stages. This information can then be applied to improve patient care overall.

Apart from this, our report covers a detailed analysis of biomarkers, liquid biopsy, NSG, AI, and big data analytics and how they are helping the global companion diagnostics market to move forward.

Early detection of diseases: By analyzing large volumes of data, companion diagnostics can detect abnormalities earlier in their development, which can help to prevent them from becoming full-blown diseases.
Improved treatment options: By understanding the genetic cause of a disease, doctors may be able to prescribe better treatments that specifically target that malignancy.
More accurate predictions: By studying patterns in patient data, companion diagnostics can make more accurate predictions about which patients will experience specific side effects or complications from treatment.
Measuring quality of health care: Quality of care can be monitored and improved by studying patterns in patient data (in disease monitoring tracking).

Partnerships are the Most Common Among Pharma Companies to Sustain in the Companion Diagnostics Market

According to a study by SkyQuest Technology, partnerships are the most common type of business alliance among pharmaceutical companies. The study found that 64% of participating companies in the companion diagnostics market have formed partnerships with other companies in the past five years. These alliances can provide complementary services, such as research and development or marketing. In addition, they can help to reduce the costs of developing new products.

The study also found that more than half of all partnering companies are from Europe. This is likely due to the prevalence of regulatory constraints and a need for greater collaboration in order to overcome them. American drug companies are less likely to form partnerships than their European counterparts, probably because the U.S. market is more competitive.

Overall, the study suggests that partnering is an effective way for pharmaceutical companies to sustain their businesses in the companion diagnostics market.

Some of the recent Partnerships, Investments, Developments in Companion Diagnostics market

In July 2022, Almac Diagnostic entered into partnership with AstraZeneca CDx. They are planning on exploring new disease area making use of NGS and qPCR
In July 2022, Guardant Health entered into partnership with Adicon Holdings Limited for carrying clinical trials
In July 2022, Integrated Graphene announced to invest up to $9.58 million in scaling up its revolutionary 3D Graphene foam, Gii®, manufacturing process to meet surging global demand from the human diagnostics and energy markets.
In July 2022, Prometheus Biosciences finished Enrollment of the ARTEMIS-UC Cohort 1 Phase 2 Study in Ulcerative Colitis. The study would evaluate the effectiveness of Prometheus’ companion diagnostic in approximately 40 patients with UC.

To understand a detailed analysis of how the global companion diagnostics market is growing, what are the investment and business expansion opportunities in the market, market dynamics, impact of current trends on future growth, and recent developments,

Speak to Analyst for your custom requirements:

https://skyquestt.com/speak-with-analyst/companion-diagnostics-market

Key Players in Companion Diagnostics Market

GE Healthcare (US)
Abbott Laboratories (US)
Hologic Inc. (US)
Agilent Technologies Inc. (US)
Roche Diagnostics (Switzerland)
FUJIFILM Corporation (Japan)
Danaher Corporation (US)
DiaSorin S.P.A. (Italy)
Myriad Genetics Inc. (US)
Siemens Healthineers AG (Germany)
BD (US)
bioMérieux SA (France)
Bio-Rad Laboratories (US)
Cancer Diagnostics Inc. (US)
Vela Diagnostics (Singapore)
Roche Diagnostics (Switzerland)
AMOY Diagnostics CO. LTD. (China)
Quidel Corporation (US)
Bio SB (US)
Biocartis NV (Belgium)
Exact Science (US)

Related Reports in SkyQuest’s Library:

Global Lymphedema Treatment Market

Global In-Vitro Diagnostics Market

Global Sleep Apnea Devices Market

Global Breast Imaging Technologies Market

Global Influenza Diagnostics Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: [email protected]

LinkedIn Facebook Twitter

Related Topics:AI Artificial Intelligence Machine learning

Up Next

Decision Point Launches OpusMXM to Help Health Plans Achieve Top Member Experience Ratings

Don't Miss

AITX’s Subsidiary Robotic Assistance Devices Signs New Dealers, Receives Multiple ROSA Orders

GlobeNewswire

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

sCrypt Launches Chain-Agnostic Developer Platform for UTXO Blockchains

Published

48 mins ago

July 1, 2024

CISION (PR Newswire)

SAN FRANCISCO, July 1, 2024 /PRNewswire/ — sCrypt, a full-stack Web3/blockchain development platform, has announced the launch of its groundbreaking developer tool kit designed for the Unspent Transaction Output (UTXO) blockchains. The new tools will revolutionise how developers interact with UTXO blockchains, making them more accessible and fostering creativity in the Web3 space.

UTXO is the method the Bitcoin protocol uses to track balances as they move between digital wallets. The UTXO model is essential for maintaining the security and integrity of blockchain networks and solves the double-spend problem.
The sCrypt platform provides comprehensive toolkits such as Software Development Kits (SDK) and Application Programming Interfaces (APIs) that allow developers to seamlessly integrate UTXO blockchains into their applications. The platform will also integrate a vast ecosystem of JavaScript/TypeScript developers, estimated at 13 million globally. These developers can now leverage their existing skills to build and operate on UTXO blockchains.
By doing so, sCrypt opens a world of opportunities, where developers are equipped with the best tools to drive innovation and success.
The SDK provides libraries in various languages, detailed documentation, and tutorials and offer a flexible and robust framework for leveraging payments, tokens, and smart contracts. Whereas APIs allow developers to read from and write into blockchains, without setting up and maintaining their own nodes and indexers. As a tool kit, they allow developers to focus on the business logic of their dApp (decentralised applications), rather than worrying about the underlying blockchain infrastructure.
The platform is chain-agnostic, allowing developers to focus all their intellectual horsepower on application development rather than blockchain specifics. This industry-first platform is designed to power Web3 growth and empower developers to build and scale their dApp efficiently and effortlessly, by leveraging UTXO’s unparalleled scalability and programmability.
Xiaohui Liu, Founder and CEO at sCrypt said, “Historically, Web3 applications have been largely built on account-based blockchains like Ethereum and Solana. Ordinals have brought renewed development interest back to Bitcoin and UTXO blockchains. With our extensive developer tooling and infrastructure, it is now easier than ever to build on UTXO blockchains, empowering builders to unleash UTXO’s superior scalability and programmability.”
Companies utilising the sCrypt platform include BTC platforms, such as Dotswap, the first BRC20 token swap platform on BTC, offer fast and seamless token exchanges, leveraging a fully functioning Automated Market Maker (AMM) and liquidity pools. It uses sCrypt’s APIs to query the status of tokens, including BRC20 and Runes. TierTopis another cutting-edge BTC trading platform that supports Ordinals NFTs, BRC-20 tokens, and bitmaps which rely on sCrypt’s token APIs.
Other businesses using sCrypt include Tokenovate, which leverages sCrypt’s smart contracts to manage trading lifecycle events of derivatives, such as interest-rate swaps and voluntary carbon credits. Additionally, various innovative applications benefiting from sCrypt’s toolkit are Hodlocker, Order Lock by RelayX, Tokenized, 1Sat Ordinals and Yours Wallet.
The sCrypt platform is poised to be a game-changer for developers working within the UTXO framework, offering them resources to develop next-generation blockchain applications and aiming to become the de-facto development platform for UTXO blockchains.
About sCrypt:sCrypt is a UTXO-blockchain development platform that offers a suite of tools and infrastructure to enhance and accelerate the development process of decentralised applications (dApps). It provides a rich set of APIs and software development kits (SDKs) that simplify blockchain interactions, such as querying blockchain data, sending transactions, issuing tokens, and developing smart contracts. It specialises in UTXO blockchains and supports multiple of them, such as Bitcoin and Bitcoin SV.

View original content:https://www.prnewswire.co.uk/news-releases/scrypt-launches-chain-agnostic-developer-platform-for-utxo-blockchains-302186804.html

Artificial Intelligence

ALLATRA President Discussed Climate Change with Pope Francis

Published

48 mins ago

July 1, 2024

CISION (PR Newswire)

allatra-president-discussed-climate-change-with-pope-francis

The Pope received the President of ALLATRA in an audience at the Vatican
VATICAN CITY, July 1, 2024 /PRNewswire/ — Pope Francis hosted distinguished scientists and experts from various countries and disciplines at a private audience at the Apostolic Palace in Vatican City. The selected attendees were participants in the Three-day International Conference on ‘Generative Artificial Intelligence and Technocratic Paradigm,’ organized by the Centesimus Annus Pro Pontifice Foundation (CAPP) – operating within the Secretariat of State of the Holy See and led by the esteemed Chairwoman, Dr. Anna Maria Tarantola.

Among the invited guests were Dr. A. Egon Cholakian, a National Security Expert, Washington D.C. Governmental Affairs Advisor to the ALLATRA International Public Movement, CAPP Foundation member; and Maryna Ovtsynova, President of the ALLATRA International Public Movement.
During the audience at the Vatican, the President of ALLATRA presented to Pope Francis a climate report ‘On The Progression Of Climatic Disasters On Earth And Their Catastrophic Consequences.’ In their personal conversation, she raised the issue of climate change as a global problem, emphasizing that it represents one of the most pressing challenges for humanity.
During the conversation, Pope Francis listened attentively and expressed his pleasure in offering his blessing to the ALLATRA International Public Movement. Following the event, Maryna Ovtsynova, President of ALLATRA, also personally received a blessing from the Holy See and Pope Francis on this significant day for the ALLATRA organization.
Additionally, the international conference featured discussions on technological innovations that are set to shape the future of civilization.
Since the future of humanity will be played out on the front of technological innovation, Pope Francis stated, “We must not miss the opportunity to think and act in a new way, with mind, heart and hands,” in order to “direct innovation toward a configuration centred on the primacy of human dignity.” – cites ‘Vatican News.’
During the event, in a pivotal discussion with conference organizers, Maryna Ovtsynova, President of the ALLATRA International Public Movement, addressed the pressing global threats to freedom and democracy. Mrs. Ovtsynova addressed the ongoing investigation into the illegal persecution of ALLATRA participants in several countries with low democracy indexes. Specifically, she detailed how they were subjected to a defamation campaign initiated by a Russian anti-cult organization. Additionally, she mentioned that this defamation campaign occurred not only in Russia but also in Ukraine, which indicates the significant influence of the Russian anti-cult organization on Ukraine.
During the conversation, Maryna Ovtsynova also raised the issue that anti-cult organizations, which exist contrary to democratic norms, cast a shadow on faith and on what Christianity stands for—freedom of religion and freedom of conscience.
During an audience on June 22, 2024, Maryna Ovtsynova expressed heartfelt gratitude to Pope Francis for his significant contributions as a responsible and decisive leader in the social integration of the Roman Catholic Church and for strengthening its role in contemporary secular society. She also thanked him for his kindness, warmth, and support during this special moment for ALLATRA.
Photo – https://mma.prnewswire.com/media/2451854/ALLATRA_Pope_Francis_Maryna_Ovtsynova.jpgPhoto – https://mma.prnewswire.com/media/2451855/Vatican_ALLATRA_collage.jpg

View original content:https://www.prnewswire.co.uk/news-releases/allatra-president-discussed-climate-change-with-pope-francis-302186790.html

Artificial Intelligence

35 Institutions Recognised for Excellence in Education and Innovation in the 2024 Anthology Catalyst Awards

Published

48 mins ago

July 1, 2024

CISION (PR Newswire)

35-institutions-recognised-for-excellence-in-education-and-innovation-in-the-2024-anthology-catalyst-awards

BOCA RATON, Fla., July 1, 2024 /PRNewswire/ — Anthology, the leading provider of education solutions that support the entire learner lifecycle, today announced the winners of the 2024 Catalyst Awards. The awards honour those driving innovation and excellence within higher education. Winners are recognised across 8 categories and selected by a cross-functional team of Anthology experts and represent the very best in their field.

This year, 35 winners were selected from among 108 nominees from institutions across 19 countries. Honourees will be recognised at the upcoming Anthology Together conference, one of the world’s largest EdTech conferences, taking place July 15-17 in Orlando, Florida.
“The Catalyst Awards celebrate what’s at the heart of higher education and technology – working together to drive student success. It’s inspiring to see the creative programmes and remarkable outcomes,” said Bruce Dahlgren, Chief Executive Officer at Anthology. “I am personally honoured to work with such an incredible community of innovators and educators as we partner together to deliver bold solutions to meet the needs of students and those who support them.”
The 2024 Anthology Catalyst Award winners by category:
Assessment & Institutional Effectiveness: This award recognises institutions that have successfully grown in their assessment practices and influenced positive behavioural changes using Anthology solutions.
Keiser University – Online Division, United States of America: The Online Academic Team – Sherry Olsen, Neha Prakash, and Marcel LarondeOdessa College, United States of America: Institutional Effectiveness Division – Connie MayUniversity of Cincinnati, United States of America: Traci SteehlerUniversity of the District of Columbia, United States of America: The Center for the Advancement of Learning & The Office of Planning and Institutional EffectivenessDiversity, Equity, Inclusion, and Belonging: This award honours those institutions leveraging technology to foster diversity, equity, inclusion, and belonging practices using Anthology solutions to ensure that their services are fully inclusive and supportive of all learners.
Grupo Ser Educacional, Brazil: EaD Management – Janyo Diniz, Joaldo Diniz, Enzo Moreira, Francislene Hasmann, and Sergio MuriloUniversity of Bahrain, Kingdom of Bahrain: Dr. Mazen AliUniversity of Derby, United Kingdom: PLT: Digital Learning and Online Content TeamUniversity of Illinois Chicago, United States of America: Landen DixonInstitutional Advancement: This award recognises institutions that have made significant changes to enhance the alumni and donor experience using Anthology solutions.
Morehead State University, United States of America: Alumni Relations & Development: Jessi Ferguson, Allie Rayburn, and Sherry SurmontUniversity of Louisville, United States of America: Communications & Marketing – Jessica Watts and Natalie TracyUniversity of Washington, United States of America: University AdvancementLeading Change: This award recognises institutions at the forefront of educational innovation that have used Anthology solutions to implement transformational initiatives that generate change on campus and in their academic ecosystems, with measurable results.
Central Michigan University, United States of America: The Office of Curriculum and Instructional Support – Marnie RoestelGrand Valley State University, United States of America: GVSU eLearning TechnologiesNorthumbria University, University of Southampton, College of DuPage, and WSU Tech, United Kingdom and United States of America. International Ally User Group: Kristen McCartney-Bulmer, Northumbria University; Matthew Deeprose, University of Southampton; Krystal Iseminger, WSU Tech; and Lara Tompkins, College of Du PageImam Abdulrahman Bin Faisal University, Kingdom of Saudi Arabia: Deanship of eLearning and Distance Learning – Dr. Muneerah B. AlmahasheerMapúa Malayan Colleges Laguna, Philippines: Mapúa Laguna 4Cers – Dr. Dodjie S. Maestrecampo, Anthony Hilmer S. Medrano, Maribel G. Songsong, Dr. Ramachandra C. Torres, Christian Dominic V. Kare, and John Mark L. AlmarezStudent Experience: This award recognises institutions leveraging technology to develop educational and administrative innovations that positively influence the total learner experience – outside and inside the classroom – and improve operational efficiency.
California Polytechnic State University, United States of America: Division of Student AffairsEdge Hill University, United Kingdom: Learning Design and Student Life TeamsMarshall University, United States of America: Enrollment Management – Dr. Jerry Ross, Dr. Beverly Boggs, and Nathan MillerSam Houston State University, United States of America: Student Involvement – Dr. Meredith Conrey and Emily FigueroaThe University of Memphis, United States of America: Dr. MK TylerStudent Success: This award recognises institutions whose innovative use of Anthology solutions has led to increased retention, increased completion, or improved outcomes through the implementation of new academic and administrative resources, data analytics solutions, scalable advising and intervention strategies and student support programmes.
Bellevue University, United States of America: College of Engineering, Technology and Management – Dr. Matthew Davis, Rebecca Barnes, and Nathan KraftJenison Innovation Academy (JIA), United States of America: JIA Leadership Team – Cameron Kuiper, Dr. Rebekah Redmer, and Krista OsterbergNorthern Border University, Kingdom of Saudi Arabia: Deanship of E-Learning and Knowledge Resources – Dr. Saud Abdul Mohsen Al-Muqahim, Dr. Sultan Munadi Al-Anazi, and Dr. Ghanim Tawash AlAnaziUniversity of Florida, George Mason University, and University of North Carolina at Charlotte, United States of America: Shared Metacognition Team: Dr: Larisa Olesova, University of Florida; David Miller, George Mason University; and Dr. Ayesha Sadaf, University of North Carolina CharlotteTeaching & Learning: This award recognises institutions that have used Anthology solutions in innovative ways to advance learning.
Beacon Red, United Arab Emirates: Knowledge Systems Team – Phil Burgess, Sean McGuinness, Anurag Patel, and Jimmy JosephTechnical and Vocational Training Corporation, Kingdom of Saudi Arabia: E-Learning Center – Abdullah Farhan Aljably and Abdullah AldukhayyelThe University of Texas at El Paso, United States of America: The Center for Instructional DesignUniversidad Abierta Interamericana, Argentina: Faculty of Information Technology – Dr. Marcelo Edgardo De Vincenzi Zemborain, Nicolás Battaglia, and Dr. Carlos NeilWestern Kentucky University, United States of America: IDST 100 Course Development Team – Catie Weaver, Alicia Pennington, Ara Sprouse, and Brittney SholarTraining & Professional Development: This award recognises institutions that display an organisation-wide dedication to innovative training and development programmes for their educators and staff.
William Paterson University, United States of America: The Center for Teaching with Technology – Dr. Jae KimUniversidad Peruana de Ciencias Aplicadas, Peru: Diseño de entornos de aprendizaje DEA – DADO Team – Jessica Vlasica, Milagros Suyo, and Nancy OlmosUniversity of Central Oklahoma, United States of America: Center for eLearning and Connected Environments – Darren DenhamUniversity of Pretoria, South Africa: E-Education GroupWichita State University, United States of America: Office of Instructional ResourcesFor more information on the 2024 Catalyst Award winners, the full list of nominees, and complete category descriptions, please visit www.anthology.com/catalystawards.
About Anthology
Anthology offers the largest EdTech ecosystem on a global scale for education, supporting more than 150 million users in 80 countries. With a mission to provide dynamic, data-informed experiences to the global education community through Anthology Intelligent Experiences™, we help learners, leaders and educators achieve their goals by offering over 60 SaaS products and services designed to advance learning. Discover more about how we are fulfilling our mission for education, business and government institutions at www.anthology.com.
Media Contact: Erin Mitchell, Director of Communications, Anthology. [email protected]
Logo – https://mma.prnewswire.com/media/1708867/Anthology_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/35-institutions-recognised-for-excellence-in-education-and-innovation-in-the-2024-anthology-catalyst-awards-302186250.html